Fintech PR
Indonesia’s Cybersecurity Market Set for Remarkable Growth, Poised to Reach $917.9M by 2028
![indonesia’s-cybersecurity-market-set-for-remarkable-growth,-poised-to-reach-$917.9m-by-2028](https://thefintechbuzz.com/wp-content/uploads/2024/02/49802-indonesias-cybersecurity-market-set-for-remarkable-growth-poised-to-reach-917-9m-by-2028.jpg)
GURUGRAM, India, Feb. 5, 2024 /PRNewswire/ — According to Ken Research, Indonesia’s cybersecurity market is on a swift ascent, projected to reach approximately USD 917.9 million by 2028. This growth, at a CAGR of 9.3% from 2023 to 2028, marks a significant shift in the digital security sector, driven by escalating cyber threats and the rapid digitalization of industries.
Market Overview: Digital Transformation at the Core
Ken Research highlights that Indonesia’s cybersecurity landscape is undergoing rapid evolution, fueled by digital transformation across various sectors. Factors such as the rise of SMEs, increased regulatory compliance, and strategic R&D investments are key drivers of this growth.
Cybersecurity Services: Addressing Rising Demands
The escalating cyber threats are pushing the demand for robust cybersecurity solutions. Services like SIEM, particularly in the banking and financial sectors, are essential for maintaining data confidentiality. These services, including cloud security and endpoint protection, are crucial in safeguarding Indonesia’s digital infrastructure.
Interested to Know More about this Report, Request a Free Sample Report
The Ecosystem: Global and Local Expertise Fusion
The Indonesian market, as reported by Ken Research, benefits from a synergy of global and local cybersecurity expertise. This collaboration is vital in addressing the unique digital security challenges faced by Indonesia.
End-User Segmentation: A Sector-Wide Impact
Predominantly, the BFSI sector, along with fintech and e-commerce, are leading the demand for advanced cybersecurity solutions. This reflects the critical need for data protection in these digitally-driven sectors.
Regional Developments: A Geographical Perspective
Regions like Borneo Island and Jakarta are experiencing significant cybersecurity investments, as indicated by Ken Research. These investments underscore the need for enhanced digital security measures in Indonesia’s key economic zones.
Visit this Link :- Request for custom report
Future Outlook: Innovations and Emerging Challenges
The future of Indonesia’s cybersecurity market, as per Ken Research, is poised for growth driven by SMEs, increased R&D, and the adoption of AI, ML, and IoT technologies. These developments are expected to shape a dynamic and challenging cybersecurity landscape.
Ken Research: Your Authority on Cybersecurity Insights
For an authoritative analysis of the Indonesian cybersecurity market, Ken Research’s comprehensive reports are indispensable. Visit Ken Research’s Cybersecurity Market Analysis for in-depth market trends, competitive landscapes, and future forecasts. Engage with our experts to navigate the complexities of cybersecurity in Indonesia and make informed strategic decisions.
Taxonomy
By Type of Cybersecurity Services
IEM
Cloud Consulting
Endpoint Security
Penetration Testing
Firewall
ITSRA
Infrastructure Security
Request free 30 minutes analyst call
By End-Users
BFSI
FinTech
E-Commerce
Public
Healthcare
Manufacturing
Others
By Region
Kalimantan Timur
Jakarta
By Origin of Company
Local Players
International Players
By Cloud Deployment
On-Premise
Cloud
By Sector Size
Public
Private
For More Insights On Market Intelligence, Refer To The Link Below: –
Indonesia Cybersecurity Market
Related Reports by Ken Research: –
In 2020, Saudi Arabia recorded 22.5 million cyberattacks. Companies, especially MSMEs, were the major targets. Therefore, enterprises are boosting investment to enhance their cybersecurity measures. The cybersecurity market in Saudi Arabia is estimated to expand at a high CAGR between 2021 and 2026E attributed to increasing demand of big data, surging internet penetration rate and roll out of 5G services across the nation. The strict regulations by the government such as ECC and Cybersecurity Framework by SAMA will also act as a catalyst for the surging growth of the cybersecurity market in Saudi Arabia.
The cybersecurity market is expected to grow at a CAGR of 16.9% over the period 2019 to 2025. Increasing adoption of cybersecurity solutions by SMEs and other enterprise segments is expected to drive market growth. New kinds of cyber threats such as Advanced Persistent Threats and IoT device attacks will encourage cybersecurity organizations in the country to enhance product capabilities and develop technologically advanced and efficient products.
The US Security Testing Market is growing every year with a successive change into their database and workflow, with an expected CAGR of ~18%, within the time period 2022 to 2028. Major changes in technologies have been seen throughout the security testing market, with more complex and stringent regulatory compliances leading to a much more secure mainframe, handling multiple scans on the software.
US Identity Verification market is expected to show increasing and is expected to grow at a CAGR of ~13% from 2022 to 2028 with Government initiatives for stricter and high-end algorithm development are expected to enhance the connectivity within the US. The rise in demand for identity verification solutions was projected to continuously grow as global digitalization and online transactions became more prevalent across all sorts of industries. The need to establish secure and trustworthy digital identities is anticipated to remain a top priority for all major business and companies.
Follow Us – LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us:-
Ken Research Private Limited
Ankur Gupta, Director Strategy and Growth
[email protected]
+91-9015378249
Logo :https://mma.prnewswire.com/media/1954972/Ken_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/indonesias-cybersecurity-market-set-for-remarkable-growth-poised-to-reach-917-9m-by-2028–302053086.html
Fintech PR
Invitation to presentation of EQT AB’s Q1 Announcement 2024
![invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024](https://thefintechbuzz.com/wp-content/uploads/2024/04/51875-invitation-to-presentation-of-eqt-abs-q1-announcement-2024.png)
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
Fintech PR
Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs
![kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs](https://thefintechbuzz.com/wp-content/uploads/2024/04/51877-kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs.jpg)
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
Fintech PR
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
![biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update](https://thefintechbuzz.com/wp-content/uploads/2024/04/51873-biovaxys-technology-corp-provides-bi-weekly-mcto-status-update.jpg)
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News4 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News4 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News5 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News5 days ago
COP28 President calls on all stakeholders to bring spirit of solidarity that delivered UAE Consensus to drive implementation and sustainable socio-economic development
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News2 days ago
KEYSTONE BANK HOLDS CUSTOMER FORUM, REITERATES COMMITMENT TO EXCELLENT SERVICE DELIVERY